South Dakota Health Center COVID-19 Survey Summary Report

Latest data from January 14, 2022

Number of Health Center respondents = 3 (75% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 4,691
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) 33.31%
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 1,667
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) 33.69%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, Antigen)2 Patients Tested Positive, Virus Detection (PCR, Antigen)2
White, Non-Hispanic/Latino Patients 63.80% 63.05%
White, Hispanic/Latino Patients 16.78% 15.12%
Black/African American, Non-Hispanic/Latino Patients 1.24% 1.32%
Black/African American, Hispanic/Latino Patients 0.64% 0.66%
Asian Patients3 2.49% 3.12%
American Indian/Alaska Native Patients3 5.76% 6.78%
Native Hawaiian/Other Pacific Islander Patients3 0.23% 0.42%
Patients with More Than One Race3 3.47% 3.42%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 1.26% 1.20%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 2.77% 2.58%
Unreported/Refused to Report Race and Ethnicity 1.56% 2.34%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 296
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 32.86%
COVID-19 Immunization Series Completed 126
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 63.79%
COVID-19 Immunization Series Additional 354
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 36.06%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 63.51% 33.33% 59.60%
White, Hispanic/Latino Patients 6.08% 5.56% 14.69%
Black/African American, Non-Hispanic/Latino Patients 0.00% 1.59% 0.28%
Black/African American, Hispanic/Latino Patients 0.00% 1.59% 0.00%
Asian Patients3 5.41% 3.97% 6.21%
American Indian/Alaska Native Patients3 17.57% 39.68% 9.04%
Native Hawaiian/Other Pacific Islander Patients3 0.34% 1.59% 0.00%
Patients with More Than One Race3 1.01% 0.79% 0.00%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.68% 3.97% 3.39%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.00% 0.00% 1.69%
Unreported/Refused to Report Race and Ethnicity 5.41% 7.94% 5.08%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)

Metrics Value
Less Than 1 Hour 100.00%
1 to 24 Hours 0.00%
More Than 24 Hours 0.00%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 0.00%
Staffing to administer the vaccine 33.33%
Vaccine confidence 33.33%
Vaccine storage capacity 0.00%
Vaccine supply 0.00%
Other 0.00%
None 33.33%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 33.33%
Average Percent of Health Center Visits Conducted Virtually 5.00%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 0.00%
Number of Mobile Van Sites 0
Number of Pop-up Clinics 0
Number of School-Based Vaccination Sites 0
Number of Family Vaccination Clinics 0

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 0.00%
Refer patients to another organization that provides monoclonal antibody therapies 66.67%
None 33.33%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 0.00%
Patient awareness/education 33.33%
Staffing capacity 0.00%
Therapy administration/onsite logistics 0.00%
Other 0.00%
None 66.67%

Test Kit Distribution

Metrics Value
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program 0
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program 0

Test Kit Distribution Methods4

Metrics Value
Provide to Existing Health Center Patients -
Provide to General Public Who Came to the Health Center -
Provide at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) -
Provide at Other Community Events -
Provide through direct outreach to specific populations (i.e., individuals experiencing homelessness, MSAWs, residents of public housing, individuals with limited English proficiency) -
Other -

Oral Antiviral Medication Distribution

Metrics Value
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program 0
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication5 -

Oral Antiviral Medication Distribution by Race and Ethnicity5

Race/Ethnicity Value
White, Non-Hispanic/Latino Patients -
White, Hispanic/Latino Patients -
Black/African American, Non-Hispanic/Latino Patients -
Black/African American, Hispanic/Latino Patients -
Asian Patients3 -
American Indian/Alaska Native Patients3 -
Native Hawaiian/Other Pacific Islander Patients3 -
Patients with More Than One Race3 -
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) -
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) -
Unreported/Refused to Report Race and Ethnicity -

Oral Antiviral Medication Distribution by Special/Vulnerable Population5

Metrics Value
Migratory/Agricultural Workers -
Patients Experiencing Homelessness -
Patients Who Are Residents of Public Housing -
Patients with Limited English Proficiency -
Children Under 18 Years of Age -

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.

5 Percentages are calculated using the number of health centers that have distributed courses of COVID-19 oral antiviral medication received through the HRSA Health Center COVID-19 Therapeutics Program as the denominator.

Date Last Reviewed:  January 2022